Patents by Inventor Anthony T. Yeung

Anthony T. Yeung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUCIN 5B AS A PANCREATIC CYST FLUID SPECIFIC BIOMARKER FOR ACCURATE DIAGNOSIS OF MUCINOUS CYSTS AND OTHER MARKERS USEFUL FOR DETECTION OF PANCREATIC MALIGNANCY
    Publication number: 20160245817
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma in a test subject are disclosed.
    Type: Application
    Filed: March 10, 2016
    Publication date: August 25, 2016
    Inventor: Anthony T. Yeung
  • Biomarkers for the diagnosis and treatment of pancreatic cancer
    Patent number: 9182383
    Abstract: Compositions and methods for use in methods and kits for the detection of an increased risk of pancreatic cancer are provided. Cyst fluid samples isolated from patients that are positive for at least three of the following markers, mucin 1, mucin 2, mucin 5AC, mucin 5B, mucin 6, CEA CAM 1, CEACAM 5, CEACAM 6, CEACAM 7, CEACAM 8, S100-A6, S100-A8, S100-A9 and S100-A11 indicate that such patients are at greater risk for development of pancreatic cancer when compared to cyst fluid samples isolated from patients lacking these markers.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: November 10, 2015
    Assignee: The Institute for Cancer Research
    Inventor: Anthony T. Yeung
  • Mucin 5B as a Pancreatic Cyst Fluid Specific Biomarker for Accurate Diagnosis of Mucinous Cysts and Other Markers Useful for Detection of Pancreatic Malignancy
    Publication number: 20140213467
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma in a test subject are disclosed.
    Type: Application
    Filed: March 19, 2012
    Publication date: July 31, 2014
    Inventor: Anthony T. Yeung
  • Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer
    Publication number: 20140103204
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma are disclosed.
    Type: Application
    Filed: December 17, 2013
    Publication date: April 17, 2014
    Applicant: The Institute for Cancer Research doing business as the Research Institute of Fox Chase Cancer Cent
    Inventors: Anthony T. Yeung, Jeffrey Tokar
  • Biomarkers for the diagnosis and treatment of pancreatic cancer
    Patent number: 8609437
    Abstract: Compositions and methods for use in methods and kits for the detection of an increased risk of pancreatic cancer are provided. Cyst fluid samples isolated from patients that are positive for at least three of the following markers, mucin 1, mucin 2, mucin 5AC, mucin 5B, mucin 6, CEA CAM 1, CEACAM 5, CEACAM 6, CEACAM 7, CEACAM 8, S100-A6, S100-A8, S100-A9 and S100-A11 indicate that such patients are at greater risk for the development of pancreatic cancer when compared to cyst fluid samples isolated from patients lacking these markers.
    Type: Grant
    Filed: January 21, 2009
    Date of Patent: December 17, 2013
    Assignee: The Institue for Cancer Research
    Inventors: Anthony T. Yeung, Jeffrey Tokar
  • Biomarkers for the Diagnosis and Treatment of Pancreatic Cancer
    Publication number: 20110008914
    Abstract: Compositions and methods which indicate an increased risk for pancreatic carcinoma are disclosed.
    Type: Application
    Filed: January 21, 2009
    Publication date: January 13, 2011
    Inventors: Anthony T. Yeung, Jeffrey Tokar
  • Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
    Patent number: 6699980
    Abstract: Nucleic acid molecules encoding a mismatch endonuclease and its method of use for the detection of mutations in targeted polynucleotide sequences are provided, which facilitate the localization and identification of mutations, mismatches and genetic polymorphisms.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: March 2, 2004
    Assignee: Fox Chase Cancer Center
    Inventor: Anthony T. Yeung
  • Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof
    Patent number: 6391557
    Abstract: Nucleic acid molecules encoding a mismatch endonuclease and its method of use for the detection of mutations in targeted polynucleotide sequences are provided, which facilitate the localization and identification of mutations, mismatches and genetic polymorphisms.
    Type: Grant
    Filed: February 22, 2000
    Date of Patent: May 21, 2002
    Assignee: Fox Chase Cancer Center
    Inventor: Anthony T. Yeung
  • Mismatch endonuclease and its use in identifying mutations in targeted polynucleotide strands
    Patent number: 5869245
    Abstract: An endonuclease and its method of use for the detection of mutations in targeted polynucleotide sequences are provided, which facilitate the localization and identification of mutations, mismatches and genetic polymorphisms.
    Type: Grant
    Filed: June 5, 1996
    Date of Patent: February 9, 1999
    Assignee: Fox Chase Cancer Center
    Inventor: Anthony T. Yeung